alexa

GET THE APP

Disrupted Blood-CSF Barrier to Urea and Creatinine in Mild Cognitive Impairment and Alzheimer's Disease | OMICS International| Abstract
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Alzheimers Dis Parkinsonism 2018, Vol 8(2): 435
  • DOI: 10.4172/2161-0460.1000435

Disrupted Blood-CSF Barrier to Urea and Creatinine in Mild Cognitive Impairment and Alzheimer's Disease

Conrad E Johanson1*, Edward G Stopa1,2, Lori Daiello3, Suzanne De La Monte, Matthew Keane2 and Brian R Ott3
1Department of Neurosurgery, Alpert Medical School at Brown University, , Rhode Island Hospital, 593 Eddy St, Providence, RI 02903, USA
2Department of Pathology, Alpert Medical School at Brown University, , Rhode Island Hospital, 593 Eddy St, Providence, RI 02903, USA
31st Department of Neurology, Alpert Medical School at Brown University, , Rhode Island Hospital, 593 Eddy St, Providence, RI 02903, USA
*Corresponding Author : Conrad E Johanson, Department of Neurosurgery, Alpert Medical School at Brown University, Rhode Island Hospital, 593 Eddy St, Providence RI 02903, USA, Tel: 4016885299, Email: [email protected]

Received Date: Mar 20, 2018 / Accepted Date: Mar 30, 2018 / Published Date: Apr 07, 2018

Abstract

Objective: In this pilot study hypothesizing that blood-CSF barrier (BCSFB) function is altered in mild cognitive impairment (MCI), we evaluated small-sized biomarker distribution between serum (SER) and cerebrospinal fluid (CSF). For both MCI and Alzheimer (AD) patients we quantified CSF neurochemistry; and compared CSF/SER ratios for urea and creatinine, as well as albumin, to those of healthy controls.
Methods: A compromised BCSFB in neurodegenerative states alters CSF-to-serum (CSF/SER) concentrations. We analyzed urea, creatinine and albumin, for transbarrier (across choroid plexus) distribution between CSF and serum, from patients with MCI (n=8) or AD (n=13). Lumbar CSF and arterial blood were frozen/analyzed by multiplex technology.
Results: In healthy controls, the CSF creatinine was significantly concentrated ~50% above the serum level. In both MCI and AD, the CSF creatinine concentration decreased while the urea level increased; CSF albumin was also elevated in AD. CSF/SER ratios for controls, MCI and AD were: urea 0.80, 0.98, 0.86; creatinine 1.52, 1.13, 1.14; and albumin 0.0045, 0.0051, 0.0065. Thus, CSF/SER ratios for creatinine and urea in MCI were similar to those in AD patients.
Conclusion: Blood-CSF barrier compromise in MCI resembled that in AD. In cognitively-impaired patients, the dissipating ratios toward equilibrium suggest disease-altered BCSFB permeability (urea and albumin) and transporter activity (creatinine/creatine). We propose that redistribution of urea and creatinine, between serum and CSF, are useful biomarkers for evaluating disease-induced alterations in CSF biochemistry and BCSFB functional status.

Keywords: Cognitive impairment; Blood-brain barrier; CSF biomarkers; Choroid plexus

Citation: Johanson CE, Stopa EG, Daiello L, de la Monte S, Keane M, et al. (2018) Disrupted Blood-CSF Barrier to Urea and Creatinine in Mild Cognitive Impairment and Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 8: 435. Doi: 10.4172/2161-0460.1000435

Copyright: ©2018 Johanson CE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top